ESC Premium Access

Heart failure with reduced ejection fraction and a narrow QRS: how can baroreflex activation therapy help?

Topic: CHF - Non pharmacological treatment
Organised by Charité Medical School, supported with an educational grant by CVRx

Presentation

About the speaker

Professor Christian Butter

Brandenburg Heart Center, Bernau bei Berlin (Germany)
11 presentations
0 follower

3 more presentations in this session

Welcome and introduction - Baroreflex activation therapy: its role in the management of heart failure and resistant hypertension.

Speaker: Professor S. Anker (Berlin, DE) Professor F. Zannad (Vandoeuvre-Les-Nancy, FR)

Thumbnail

Why is the baroreflex a relevant target for both resistant hypertension and heart failure?

Speaker: Professor A. Pathak (Monaco, MC)

Thumbnail

Resistant hypertension: stimulating the baroreflex when drugs have failed.

Speaker: Professor P. De Leeuw (Maastricht, NL)

Thumbnail

Access the full session

Baroreflex activation therapy: its role in the management of heart failure and resistant hypertension

Speakers: Professor C. Butter, Professor S. Anker, Professor F. Zannad, Professor A. Pathak, Professor P. De Leeuw
Thumbnail

About the event

Image

ESC CONGRESS 2017

26 August - 30 August 2017

Sessions Presentations

This platform is supported by

logo Novo Nordisk